Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study.
Hsu CL, Wen YW, Wang HM, Hsieh CH, Liao CT, Lee LY, Ng SH, Lin CY, Chen WC, Lin JC, Tsai YT, Lee SR, Chien CY, Hua CH, Wang CP, Chen TM, Terng SD, Tsai CY, Fan KH, Yeh CH, Lin CH, Tsao CK, Cheng NM, Fang TJ, Huang SF, Kang CJ, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT.
Hsu CL, et al. Among authors: kang cj.
Cancer Med. 2024 Aug;13(15):e70061. doi: 10.1002/cam4.70061.
Cancer Med. 2024.
PMID: 39101462
Free PMC article.